Die vorgeschlagene Klasse von mehreren tausend Patienten behauptet, dass Cigna und sein Abrechnungsvertrag MultiPlan gegen ERISA versto\u00dfen haben, indem sie Absprachen getroffen haben, um Anspr\u00fcche au\u00dferhalb des Netzwerks f\u00fcr Behandlungen von Substanzgebrauchsst\u00f6rungen zu niedrig zu bezahlen. <\/p>\n\n\n\n
Wie Law360 berichtet: <\/p>\n\n\n\n
The proposed class said that for all claims at issue, Cigna verified to patients’ providers on the phone that claims for mental health and substance use disorder treatments would be reimbursed at what’s known as the “usual, customary and reasonable,” or UCR, rate. The UCR rate is a composite rate based on similar providers in the same geographic area. But when claims were later priced using a methodology of MultiPlan subsidiary Viant, reimbursements were calculated using much lower rates, the proposed class said, in a scheme that they allege violated the Racketeer Influenced and Corrupt Organizations Act.<\/p>\n\n\n\n
Napoli Shkolnik Senior Associate Wendy A. Mitchel<\/a>l vertritt die vorgeschlagene Klasse zusammen mit anderen Anwaltskanzleien. <\/p>\n\n\n\n